These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33187821)

  • 21. Dosimetric benefit of a new ophthalmic radiation plaque.
    Marwaha G; Wilkinson A; Bena J; Macklis R; Singh AD
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1226-30. PubMed ID: 22658440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.
    Miras H; Terrón JA; Lallena AM
    Phys Med; 2013 Nov; 29(6):670-6. PubMed ID: 22858007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monte Carlo-based dosimetry of proposed bi-radionuclide (
    Mishra S; Selvam TP; Sahoo S; Saxena SK; Kumar Y; Sapra BK
    Med Phys; 2024 Oct; 51(10):7561-7573. PubMed ID: 38935327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantifying the dosimetric influences of radiation coverage and brachytherapy implant placement uncertainty on eye plaque size selection.
    Gagne NL; Rivard MJ
    Brachytherapy; 2013; 12(5):508-20. PubMed ID: 23466357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial evaluation of Advanced Collapsed cone Engine dose calculations in water medium for I-125 seeds and COMS eye plaques.
    Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
    Med Phys; 2018 Mar; 45(3):1276-1286. PubMed ID: 29383721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 16 mm OSU-Nag and COMS eye plaques.
    Zhang H; Davidorf F; Qi Y
    J Appl Clin Med Phys; 2012 May; 13(3):3632. PubMed ID: 22584165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose characteristics of Au-198 eye brachytherapy applicator: A Monte Carlo study.
    Kamrani S; Aghamiri SMR; Hashemi S
    Appl Radiat Isot; 2021 Oct; 176():109866. PubMed ID: 34293507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.
    Asadi S; Vaez-zadeh M; Masoudi SF; Rahmani F; Knaup C; Meigooni AS
    J Appl Clin Med Phys; 2015 Sep; 16(5):344–357. PubMed ID: 26699318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monte Carlo dosimetry of the eye plaque design used at the St. Erik Eye Hospital for (125)I brachytherapy.
    Karlsson M; Nilsson J; Lundell M; Carlsson Tedgren A
    Brachytherapy; 2014; 13(6):651-6. PubMed ID: 24950821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy.
    Knutsen S; Hafslund R; Monge OR; Valen H; Muren LP; Rekstad BL; Krohn J; Dahl O
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1159-66. PubMed ID: 11704341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved treatment planning for COMS eye plaques.
    Astrahan MA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incorporating patient-specific CT-based ophthalmic anatomy in modeling iodine-125 eye plaque brachytherapy dose distributions.
    Tien CJ; Astrahan MA; Kim JM; Materin M; Chen Z; Nath R; Liu W
    Brachytherapy; 2017; 16(5):1057-1064. PubMed ID: 28778599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetric study of the 15 mm ROPES eye plaque.
    Granero D; Pérez-Calatayud J; Ballester F; Casal E; de Frutos JM
    Med Phys; 2004 Dec; 31(12):3330-6. PubMed ID: 15651616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of dose to the macula, optic disc, and lens in relation to vision toxicities - A retrospective study using COMS eye plaques.
    Oare C; Sun S; Dusenbery K; Reynolds M; Koozekanani D; Gerbi B; Ferreira C
    Phys Med; 2022 Sep; 101():71-78. PubMed ID: 35981450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel low-kVp beamlet system for choroidal melanoma.
    Esquivel C; Fuller CD; Waggener RG; Wong A; Meltz M; Blough M; Eng TY; Thomas CR
    Radiat Oncol; 2006 Sep; 1():36. PubMed ID: 16965624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental validation of a new COMS-like 24 mm eye plaque for the treatment of large ocular melanoma tumors.
    McCauley Cutsinger S; Forsman R; Corner S; Deufel CL
    Brachytherapy; 2019; 18(6):890-897. PubMed ID: 31444131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between beta radiation dose distribution due to LDR and HDR ocular brachytherapy applicators using GATE Monte Carlo platform.
    Mostafa L; Rachid K; Ahmed SM
    Phys Med; 2016 Aug; 32(8):1007-18. PubMed ID: 27499370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation and comparison of 3D dosimetric reference datasets for COMS eye plaque brachytherapy using model-based dose calculations.
    Fletcher EM; Ballester F; Beaulieu L; Morrison H; Poher A; Rivard MJ; Sloboda RS; Vijande J; Thomson RM
    Med Phys; 2024 Jan; 51(1):694-706. PubMed ID: 37665982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetry for 125I seed (model 6711) in eye plaques.
    Chiu-Tsao ST; Anderson LL; O'Brien K; Stabile L; Liu JC
    Med Phys; 1993; 20(2 Pt 1):383-9. PubMed ID: 8497229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.